Cancer cells eventually adapt to oncogene-induced RS, however, by overexpressing downstream components of the ATR pathway, such as Claspin, Timeless, and CHK1, which correlates with poor prognosis in breast, lung, and colon carcinomas (Bianco et al., 2019). The gene discussed is CHEK1; the disease is cancer.